Trial Profile
The Effect of Pregnancy on the Pharmacokinetics of Isentress: A Longitudinal Investigation in the Second and Third Trimesters
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2024
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 01 Feb 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 09 Dec 2010 New trial record